|
21U014, 125 mg/5 ml, 60 ml/Btl現行藥物外觀
中文名: 優力黴素
廠牌:優良
|
| Product
name |
|
| Dosage
form |
|
21U014, 125 mg/5 ml, 60 ml/Btl |
|
| Indications |
| Usual dose;
Uncomplicated Cystitis; Pharyngitis; Skin and soft tissue infections; Tonsillitis;
Otitis media;
Pharyngitis; Skin and soft tissue infections; Tonsillitis
|
|
| Administration
& Dosage |
Adult and pediatric≧ 40kg
Usual dose:
Mild to moderate infection: 250 mg q6h.
Severe infection: < 1 g q6h.
Uncomplicated Cystitis; Pharyngitis; Skin and soft tissue infections; Tonsillitis: 500 mg q12h.
Max. 4 g/d
Pediatric> 1 yrs and<40 kg
Usual dose:
Mild to moderate infection: 12.5- 25 mg /kg q12h; or 6.25-12.5 mg /kg q6h.
Severe infection: 25- 50 mg /kg q12h; or 12.5- 25 mg /kg q6h.
Otitis media: 18.75- 25 mg/kg q6h.
Pharyngitis; Skin and soft tissue infections; Tonsillitis:
12.5-25 mg /kg q12h.
Infants and children 1 mo- 1 yr
Usual dose: 6.25 to 12.5 mg /kg q 6
Max. g for prophylaxis of bacterial endocarditis |
|
| Contraindication |
| hypersensitivity to cephalosporins. |
|
| Precaution |
|
| Adverse
reaction |
M:Eosinophilia; GI reactions; headache; oral or vaginal candidiasis; stool changes (with cefixime)
L:Hypersensitivity reactions(More with cefazolin); hypoprothrombinemia; pseudomembranous colitis; thrombophlebitis; urticaria
R: Allergic reactions; severe skin reaction; hearing loss(more with cefuroxime); hemolytic anemia; leukopenia, neutropenia, or thrombocytopenia; renal dysfunction; serum sickness–like reactions; seizures(high doses or renal function impairment)
L&R: Dizziness; drug fever; dyspepsia; flatulence; pruritus; skin rash; vaginitis |
|
| Drug
Interaction |
|
| Pregnancy
Category |
|
| Notes |
|
